Real-World Retrospective Review of Axial Neck Pain Relief

0
42


– Data introduced at Pacific Spine Pain Society annual assembly –

CLEVELAND, Sept. 21, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics shared knowledge on the use of peripheral nerve stimulation (PNS) to ship ache aid for sufferers affected by axial neck ache on the Pacific Spine Pain Society annual assembly in Las Vegas. This anonymized real-world knowledge from sufferers who underwent business placement of the SPRINT® PNS System offers an vital and insightful take a look at how PNS performs throughout a wider vary of sufferers than would possibly enroll in a managed trial. This non-destructive therapy was delivered to efferent fibers within the cervical medial department nerves. Based on the retrospective evaluation, 83 p.c of sufferers had been responders, outlined as no less than a 50% discount in ache and/or a clinically vital enchancment in high quality of life.

The therapy of axial neck ache represents a big medical want and vital medical alternative as an estimated ten p.c of the U.S. grownup inhabitants at any given time are affected by this particular, typically debilitating ache. Sixty-day percutaneous PNS has emerged as a possible, non-destructive therapy that can be utilized for axial neck ache by concentrating on efferent fibers within the cervical medial department nerves to provide snug biking rigidity in core cervical musculature (e.g., multifidus). Use of the SPRINT PNS System to stimulate the cervical medial department nerves in an on-label method to handle neck ache presents a substitute for generally used therapies comparable to opiates, nonsteroidal anti-inflammatory medication, muscle relaxants, spinal injections and surgical intervention.

See also  A Global Benchmark of App Performance

“The use of SPRINT PNS as an effective, minimally-invasive option is a tremendous advancement for both physicians and patients that are seeking to find a treatment option to address ongoing axial neck pain without having to resort to surgical intervention,” mentioned Dr. Ryan Mattie, Lead Author, and Interventional Pain Management Physician Pain Cedars-Sinai Medical Center.

About the SPRINT® PNS System
The SPRINT® PNS System, by SPR® Therapeutics, marks an progressive shift within the therapy of ache. Our breakthrough, 60-day therapy is a First-Line PNS choice uniquely proposed to recondition the central nervous system to present vital and sustained aid from persistent ache — with out a everlasting implant, nerve destruction or the danger of dependancy. The system has been studied extensively for low again ache, shoulder ache, post-amputation ache, and persistent and acute post-operative ache, is cleared to be used as much as 60 days, and is acknowledged by main ache administration facilities. Market analysis signifies that this breakthrough neuromodulation therapy is a patient-preferred different to extra invasive choices.

The SPRINT PNS System is indicated for as much as 60 days for: Symptomatic aid of persistent, intractable ache, post-surgical and post-traumatic acute ache; symptomatic aid of post-traumatic ache; symptomatic aid of post-operative ache. The SPRINT PNS System just isn’t supposed to deal with ache within the area innervated by the cranial and facial nerves.

Physicians ought to use their greatest judgment when deciding when to make use of the SPRINT PNS System. For extra data see the SPRINT PNS System IFU. Most widespread antagonistic occasions are pores and skin irritation and erythema. Results could differ. Rx solely.

See also  Cerevance Appoints Ottavio V. Vitolo, M.D., as Chief

For further data relating to security and efficacy, go to: SPR Safety Information.

About SPR Therapeutics, Inc.
SPR Therapeutics is a privately held medical machine firm, offering sufferers with a non-opioid, minimally invasive ache therapy choice. Our SPRINT® PNS System fulfills a crucial unmet want for a drug-free, surgery-free choice for hundreds of thousands that suffer from persistent ache. Backed by the most important physique of medical proof in peripheral nerve stimulation for the therapy of ache, SPR has demonstrated business demand in untapped peripheral (shoulder and knee) and again ache markets and constructed an extremely robust basis for business development. Headquartered in Cleveland, OH with satellite tv for pc workplaces in Chapel Hill, NC and Minneapolis, MN, SPR’s Senior Management workforce consists of skilled business veterans with practically 200 years of collective ache market and MedTech experience, all pushed by our objective – to enhance the standard of sufferers’ lives by offering them with a minimally-invasive, drug-free, surgery-free resolution to handle their acute and persistent ache.

More data may be discovered at www.SPRTherapeutics.com.

SPR Contacts:
Michelle McDonald
Vice President – Marketing
mmcdonald@sprtherapeutics.com
844.378.9108

Dave Folkens
Public Relations
dfolkens@sprtherapeutics.com
612.978.6547



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here